EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

4‐Octyl itaconate blocks GSDMB ‐mediated pyroptosis and restricts inflammation by inactivating granzyme A

Wenbin Gong iD, Hangyu Fu, Kui Yang, Tao Zheng, Kun Guo, Wei Zhao

Cell Proliferation · 2024

DOI: 10.1111/cpr.13711 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Proliferation, 2024. Verfasst von Wenbin Gong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Colitis, Pyroptosis, Gasdermins, Succinates. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Institutional Foundation of The First Affiliated Hospital of Xi'an Jiaotong University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

GSDMB‐mediated pyroptosis facilitates a pro‐inflammatory immune microenvironment and needs to be tightly regulated to avoid excessive inflammation. Here, we provide evidence that itaconate and its cell‐permeable derivative 4‐octyl itaconate (4‐OI) can significantly inhibit GSDMB‐rendered pyroptotic activity independent of Nrf2. 4‐OI interferes proteolytic process of GSDMB by directly modifying Cys54, Cys148 and Ser212 on granzyme A (GrzA), a serine protease that site‐specifically cleaves the inter‐domain linker of GSDMB, instead of interaction with GSDMB, thereby blocking pyroptosis and exerts anti‐inflammatory effects. Moreover, 4‐OI alleviates inflammation by suppressing GSDMB‐induced pyroptotic cell death during acute colitis models in intestinal epithelial GSDMB conditional transgenic mice. Our data expand the role of 4‐OI as a crucial immunometabolic derivative that regulates innate immunity and inflammation through a newly identified posttranslational modification, and targeting of pyroptosis by 4‐OI therefore holds potent therapeutic potential for primarily inflammatory and/or autoimmune diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisPyroptosisGasderminsSuccinatesGranzymesMice, TransgenicDisease Models, AnimalDextran SulfateProteolysisIntestinal MucosaImmunity, InnateProtein Processing, Post-TranslationalCaco-2 CellsHEK293 CellsHumansMaleAnimalsMiceMice, Inbred C57BL

Substanzen

Dextran SulfateGasdermins4-octyl itaconateSuccinatesGranzymes

Autor:innen und Institutionen

  • Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
  • Department of General Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of General Surgery, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.

ORCID-Profile: Wenbin Gong

Förderung

  • National Natural Science Foundation of China
  • Institutional Foundation of The First Affiliated Hospital of Xi'an Jiaotong University

Zitieren

APA

Gong, W., Fu, H., Yang, K., Zheng, T., Guo, K., & Zhao, W. (2024). 4‐Octyl itaconate blocks GSDMB ‐mediated pyroptosis and restricts inflammation by inactivating granzyme A. Cell Proliferation. https://doi.org/10.1111/cpr.13711

Vancouver

Gong W, Fu H, Yang K, Zheng T, Guo K, Zhao W. 4‐Octyl itaconate blocks GSDMB ‐mediated pyroptosis and restricts inflammation by inactivating granzyme A. Cell Proliferation. 2024. doi:10.1111/cpr.13711

BibTeX
@article{Gong2024,
  author = {Gong, Wenbin and Fu, Hangyu and Yang, Kui and Zheng, Tao and Guo, Kun and Zhao, Wei},
  title = {4‐Octyl itaconate blocks GSDMB ‐mediated pyroptosis and restricts inflammation by inactivating granzyme A},
  journal = {Cell Proliferation},
  year = {2024},
  doi = {10.1111/cpr.13711}
}
Kostenlos starten →